4.7 Letter

Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Decreased Bone Turnover Despite Persistent Secondary Hyperparathyroidism during Prolonged Treatment with Imatinib

Susannah O'Sullivan et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Letter Oncology

Dasatinib in relapsed or plateau-phase multiple myeloma

Tanya M. Wildes et al.

LEUKEMIA & LYMPHOMA (2009)

Letter Hematology

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia

Sofia Jonsson et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)

Article Endocrinology & Metabolism

PDGF receptor beta is a potent regulator of mesenchymal stromal cell function

Ayano Tokunaga et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2008)

Article Cell Biology

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

Chen Zhao et al.

CELL METABOLISM (2006)

Article Cell Biology

Decreased c-Src expression enhances osteoblast differentiation and bone formation

M Marzia et al.

JOURNAL OF CELL BIOLOGY (2000)